Favipiravir
- India
Government’s effort to augment domestic production ensured supply-demand balance of COVID 19 treatment drugs
98.87 lakh vials of Remdesivir allocated to States/UTs & Central Institutions from 21st April – 30th May 21 Remdesivir production…
Read More » - Ministry of Chemicals and Fertilizers
Government monitoring supply of each COVID-19 Essential Drug
Minister of State Shri Mansukh Mandaviya today assured that the Government is monitoring supply of each COVID-19 Essential Drug. All…
Read More » - Business
Zhejiang Export Online Fair on Pharmaceutical and Epidemic Prevention Products for India- 2021
New Delhi, Delhi, India: The pandemic has created an environment where businesses need to be innovative to meet the challenges of…
Read More » - India
Health Ministry issues FAQs on better Clinical Management of COVID patients in ICUs
India continues to report one of the lowest COVID Case Fatality Rates (CFR) when compared to several other countries. While…
Read More » - COVID-19
Fusion Health Care Launches COVID-19 Drug Favipiravir and an Immunity Booster
Hyderabad, India: Fusion Health Care Pvt Ltd, a leading innovative pharmaceutical company based at Hyderabad, has announced the launch of its Favipiravir…
Read More »